Landscape of immune-related signatures induced by targeting of different epigenetic regulators in melanoma: implications for immunotherapy
Articolo
Data di Pubblicazione:
2022
Citazione:
Landscape of immune-related signatures induced by targeting of different epigenetic regulators in melanoma: implications for immunotherapy / Anichini, A., Molla, A., Nicolini, G., Perotti, V.E., Sgambelluri, F., Covre, A., Fazio, C., Lofiego, M.F., Di Giacomo, A.M., Coral, S., Manca, A., Sini, M.C., Pisano, M., Noviello, T., Caruso, F., Brich, S., Pruneri, G., Maurichi, A., Santinami, M., Ceccarelli, M., et al.. - In: JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH. - ISSN 1756-9966. - 41:1(2022). [10.1186/s13046-022-02529-5]
Abstract:
Improvement of efficacy of immune checkpoint blockade (ICB) remains a major clinical goal. Association of ICB with immunomodulatory epigenetic drugs is an option. However, epigenetic inhibitors show a heterogeneous landscape of activities. Analysis of transcriptional programs induced in neoplastic cells by distinct classes of epigenetic drugs may foster identification of the most promising agents.
Tipologia CRIS:
1.1 Articolo in rivista
Keywords:
Epigenetic drugs; Guadecitabine; Immune-related signatures; Innate immunity; Melanoma
Elenco autori:
Anichini, Andrea; Molla, Alessandra; Nicolini, Gabriella; Perotti, Valentina Eleonora; Sgambelluri, Francesco; Covre, Alessia; Fazio, Carolina; Lofiego, Maria Fortunata; Di Giacomo, Anna Maria; Coral, Sandra; Manca, Antonella; Sini, Maria Cristina; Pisano, Marina; Noviello, Teresa; Caruso, Francesca; Brich, Silvia; Pruneri, Giancarlo; Maurichi, Andrea; Santinami, Mario; Ceccarelli, Michele; Palmieri, Giuseppe; Maio, Michele; Mortarini, Roberta
Link alla scheda completa:
Link al Full Text:
Pubblicato in: